http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-122966-U
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-54 |
| filingDate | 2017-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | UA-122966-U |
| titleOfInvention | METHOD OF TREATMENT OF DIABETIC RETINOPATHY BY PREPARATIONS FROM MATERIAL OF EMBRIOPHETAL ORIGIN AND SEPARATED FROM ITS CELLS |
| abstract | A method of treating diabetic retinopathy, comprising the preparation and administration of a preparation from a material of embryo-fetal origin and cells isolated from it in suspension. At least three preparations of embryo-fetal origin and its isolated cells are prepared and administered in the form of thawed suspensions of stem cells after cryopreservation, each containing a therapeutically effective amount of stem cells isolated from human fetal material 7-9 weeks. One suspension contains fetal liver stem cells and the second suspension contains fetal brain stem cells, the third suspension contains fetal mesenchymal stem cell precursor cells. A suspension of cryopreserved stem cells from fetal liver is administered intravenously in a volume of not less than 0.1 ml with the number of nucleated cells of not less than 1.81 × 106 in 1 ml per injection. A suspension of cryopreserved stem cells of the fetal brain of a human fetus is administered subcutaneously in a volume of not less than 0.5 ml with a cell number of not less than 1.32 × 106 in 1 ml per administration. A suspension of cryopreserved precursor cells of fetal mesenchymal stem cells is administered retrobulbar in a volume of not less than 0.1 ml with a cell count of at least 1.01 × 106 in 1 ml per administration. These suspensions of stem cells are administered simultaneously with standard therapy, and before the introduction of a suspension of cryopreserved stem cells from fetal liver additionally perform premedication. |
| priorityDate | 2017-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547 |
Total number of triples: 13.